Tuesday, December 13, 2005


Hepatitis C Awareness - A Phase 2 Study of Albuferon in Combination with Ribavirin in non-responders to proir interferon therapy for c


A Phase 2 Study of Albuferon in Combination with Ribavirin in non-responders to proir interferon therapy for c
National AIDS Treatment Advocacy Project - Health Medical Phase 2 Study of Albuferon in Combination with Ribavirin in non-responders to proir interferon therapy for chronic Hepatitis C Conference Reports for NATAP AASLD American